Supplement 7.1 of the European Pharmacopoeia

The European Pharmacopoeia (Ph. Eur.) is a reference work for the quality control of medicines in the signatory states of the Convention.

36 Member States and the European Union are signatory to the Convention on the Elaboration of a European Pharmacopoeia. 8 European countries, 14 non-european countries and the World Health Organization (WHO) are observers.

(Ph. Eur. Members and Observers).

The official standards published by the European Pharmacopoeia provide a legal and scientific basis for quality control during the development, production and marketing processes of medicinal products and substances for pharmaceutical use.

The texts are updated regularly taking into account changes in marketed products and scientific progress. The 7th Edition of the European Pharmacopoeia was implemented on the 1st January 2011. It comprises the texts published on the 6th Edition, eventually revised or corrected, and new texts. Supplement 7.1 of the European Pharmacopoeia was implemented on the 1st April 2011.

The Ph. Eur. is published by the EDQM (Council of Europe). (See the publication schedule of the Ph. Eur.).

Source : Swissmedic (the Swiss agency for the authorisation and supervision of therapeutic products) and the EDQM (Council of Europe).